CN101264197A - Medicine for treating sciatica - Google Patents
Medicine for treating sciatica Download PDFInfo
- Publication number
- CN101264197A CN101264197A CNA2008100973299A CN200810097329A CN101264197A CN 101264197 A CN101264197 A CN 101264197A CN A2008100973299 A CNA2008100973299 A CN A2008100973299A CN 200810097329 A CN200810097329 A CN 200810097329A CN 101264197 A CN101264197 A CN 101264197A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- sciatica
- radix
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for sciatica, prepared by eleven Chinese herbs: olibanum, myrrh, safflower, Xueke, madder, rhizomadrynariae, native copper, notoginseng, ground beetle, teasel, and cucumber seed. The medicine has the advantages of rational medicine use, scientific compatibility, significant therapeutic effect, nontoxic, medicine safety and reliability, effectively treating sciatica, improving patients' life quality, rather good cure and rehabilitation effect, and an ideal medicine for sciatica.
Description
Technical field
The invention belongs to technical field of Chinese medicines, particularly relating to a kind of is the medicine of the treatment sciatica made of raw material with the Chinese herbal medicine.
Background technology
At present, sciatica is a kind of commonly encountered diseases that has a strong impact on health of people.Sciatica is meant the sciatic nerve pathological changes, be waist, buttocks, thigh along the sciatic nerve path after, the outside and the foot outside take place behind the shank pain symptom group.Present Therapeutic Method has part massage, physical therapy, acupuncture, massage etc.Drug therapy such as oral anti-inflammation analgesic.But curative effect is not too obvious, and healing time is longer, and not thorough except that disease, relapse rate is higher, can not effect a radical cure.
Summary of the invention
The objective of the invention is to overcome above-mentioned the deficiencies in the prior art, provide a kind of nontoxic, have no side effect, therapeutic effect obviously, the medicine of the treatment sciatica of no sequel.
Solution of the present invention is, on the basis to the cause of disease of sciatica disease, pathology understanding, by inventor's clinical practice for many years, according to the pharmacology and the property of medicine of Chinese herbal medicine, it is as follows to have proposed technical scheme of the present invention:
The present invention is made by the following weight parts proportion raw material:
1～5 part of Olibanum, 1～5 part of Myrrha, 1～5 part on Flos Carthami, 1～5 part of thirst due to hemorrhage, 1～5 part in Radix Rubiae, 1～5 part of Rhizoma Drynariae, 1～5 part of Pyritum, 1～5 part of Radix Notoginseng, 1～5 part of Eupolyphaga Seu Steleophaga, 1～5 part of Radix Dipsaci, 1～5 part of Semen Cucumidis sativi.
The weight portion proportioning of each raw material of optimization formula of the present invention is:
2～4 parts of Olibanums, 2～4 parts of Myrrhas, 2～4 parts on Flos Carthami, 2～4 parts of thirst due to hemorrhage, 2～4 parts in Radix Rubiae, 2～4 parts of Rhizoma Drynariae, 2～4 parts of Pyritums, 2～4 parts of Radix Notoginseng, 2～4 parts of Eupolyphaga Seu Steleophagas, 2～4 parts of Radix Dipsacis, 2～4 parts of Semen Cucumidis sativi.
The weight portion proportioning of each raw material of optimum formula of the present invention is:
3 parts of Olibanums, 3 parts of Myrrhas, 3 parts on Flos Carthami, 3 parts of thirst due to hemorrhage, 3 parts in Radix Rubiae, 3 parts of Rhizoma Drynariae, 3 parts of Pyritums, 3 parts of Radix Notoginseng, 3 parts of Eupolyphaga Seu Steleophagas, 3 parts of Radix Dipsacis, 3 parts of Semen Cucumidis sativi.
The process for preparing medicine that the present invention treats sciatica is: the said medicine pulverize separately is become fine powder more than 200 orders, and compounding is according to the above ratio closed and can be made the drug powder that the present invention treats sciatica.The medicine that the present invention treats sciatica can also adopt multiple dosage form, as making honeyed pill, capsule and tablet etc.
Clinical drug of the present invention uses the result to show, following advantage is arranged: 1, the Chinese herbal medicine each component selected for use of the present invention meets the regulation of The Drug Administration Law of People's Republic of China, utilize the comprehensive function treatment sciatica of the Chinese medicine of respectively distinguishing the flavor of, do not have chemical sweeting agent, nontoxic to human body.2, show that through animal acute toxicity experiment the animal of being tested does not see any toxic reaction, safety of medicine is reliable.3, the present invention need not decoct, and no bitterness sense contains multiple nutritional components and various trace elements in the medicine, be beneficial to absorption of human body, health invigorating, and taking convenience.4, the present invention can treat sciatica effectively, has improved patient's life quality greatly, and higher healing rehabilitation efficacy is arranged.
For showing medicine of the present invention to the sciatica therapeutic effect, the inventor has carried out clinical practice to 50 sciatica patients, and observes and to follow up a case by regular visits to and to have write down effect: man's 28 examples wherein, woman's 22 examples; 42～73 years old age.Take embodiment 1 powder, morning, taking medicine before meal usefulness once a day, was once obeyed 15g, and 15 days is a course of treatment, take continuously three the course of treatment observe the curative effect.Cure 26 examples and account for 52%, 21 examples that take a turn for the better account for 42%, and more 3 examples do not account for 6%, and total effective rate reaches more than 94%.After three course of therapy, symptoms such as patient's pain all have obvious change or recovery from illness.And patient does not have any untoward reaction, and three big routine tests and hepatic and renal function detect no abnormal.
The specific embodiment
Embodiment 1: take by weighing raw material by following part by weight: 3 parts of Olibanums, 3 parts of Myrrhas, 3 parts on Flos Carthami, 3 parts of thirst due to hemorrhage, 3 parts in Radix Rubiae, 3 parts of Rhizoma Drynariae, 3 parts of Pyritums, 3 parts of Radix Notoginseng, 3 parts of Eupolyphaga Seu Steleophagas, 3 parts of Radix Dipsacis, 3 parts of Semen Cucumidis sativi.Each raw material pulverize separately is become 200 order fine powders, in the packaging bag of packing into, every packed 15g.Morning, taking medicine before meal usefulness once a day, was once obeyed 15g, and 15 days is a course of treatment.
Embodiment 2: take by weighing raw material by following part by weight: 5 parts of Olibanums, 4 parts of Myrrhas, 2 parts on Flos Carthami, 4 parts of thirst due to hemorrhage, 4 parts in Radix Rubiae, 3 parts of Rhizoma Drynariae, 1 part of Pyritum, 5 parts of Radix Notoginseng, 1 part of Eupolyphaga Seu Steleophaga, 2 parts of Radix Dipsacis, 2 parts of Semen Cucumidis sativi.Each raw material pulverize separately is become 200 order fine powders, in the packaging bag of packing into, every packed 15g.Morning, taking medicine before meal usefulness once a day, was once obeyed 15g, and 15 days is a course of treatment.
Embodiment 3: take by weighing raw material by following part by weight: 4 parts of Olibanums, 5 parts of Myrrhas, 2 parts on Flos Carthami, 3 parts of thirst due to hemorrhage, 5 parts in Radix Rubiae, 5 parts of Rhizoma Drynariae, 2 parts of Pyritums, 4 parts of Radix Notoginseng, 2 parts of Eupolyphaga Seu Steleophagas, 4 parts of Radix Dipsacis, 3 parts of Semen Cucumidis sativi.Each raw material pulverize separately is become 200 order fine powders, in the packaging bag of packing into, every packed 15g.Morning, taking medicine before meal usefulness once a day, was once obeyed 15g, and 15 days is a course of treatment.
Embodiment 4: take by weighing raw material by following part by weight: 5 parts of Olibanums, 3 parts of Myrrhas, 3 parts on Flos Carthami, 2 parts of thirst due to hemorrhage, 4 parts in Radix Rubiae, 5 parts of Rhizoma Drynariae, 1 part of Pyritum, 3 parts of Radix Notoginseng, 3 parts of Eupolyphaga Seu Steleophagas, 5 parts of Radix Dipsacis, 4 parts of Semen Cucumidis sativi.Each raw material pulverize separately is become 200 order fine powders, in the packaging bag of packing into, every packed 15g.Morning, taking medicine before meal usefulness once a day, was once obeyed 15g, and 15 days is a course of treatment.
Be four model case therapeutic effect below:
Li Chenghao, the man, 46 years old, sick time was longer, after the multi-treatment effect is undesirable, begin to take embodiment 1 powder in May, 91 during one's sickness, morning taking medicine before meal usefulness, once a day, once obey 15g, take and be clearly better a course of treatment, take and return to one's perfect health recurrence more so far the 3rd course of treatment.
The gold spring flower, the woman, 53 years old, 90 years make a definite diagnosis was sciatica, took embodiment 2 powder in February, 92, morning, taking medicine before meal usefulness once a day, was once obeyed 15g, took just to be clearly better in seven days, took to return to one's perfect health second course of treatment, so far not recurrence again.
Li Xiangnv, the woman, 62 years old, 2000 make a definite diagnosis was sciatica, took embodiment 4 powder November calendar year 2001, morning, taking medicine before meal usefulness once a day, was once obeyed 15g, took to return to one's perfect health three courses of treatment, so far not recurrence again.
Cui Qinglong, the man, 54 years old, 94 years make a definite diagnosis was sciatica, took embodiment 3 powder in August, 97, morning, taking medicine before meal usefulness once a day, was once obeyed 15g, took just to be clearly better a course of treatment, took to return to one's perfect health second course of treatment, so far not recurrence again.
Claims (3)
1, a kind of medicine for the treatment of sciatica, it is characterized in that: it is made by the following weight parts proportion raw material: 1～5 part of Olibanum, 1～5 part of Myrrha, 1～5 part on Flos Carthami, 1～5 part of thirst due to hemorrhage, 1～5 part in Radix Rubiae, 1～5 part of Rhizoma Drynariae, 1～5 part of Pyritum, 1～5 part of Radix Notoginseng, 1～5 part of Eupolyphaga Seu Steleophaga, 1～5 part of Radix Dipsaci, 1～5 part of Semen Cucumidis sativi.
2, the medicine of treatment sciatica according to claim 1, wherein the weight portion proportioning of each raw material of Chinese medicine is: 2～4 parts of Olibanums, 2～4 parts of Myrrhas, 2～4 parts on Flos Carthami, 2～4 parts of thirst due to hemorrhage, 2～4 parts in Radix Rubiae, 2～4 parts of Rhizoma Drynariae, 2～4 parts of Pyritums, 2～4 parts of Radix Notoginseng, 2～4 parts of Eupolyphaga Seu Steleophagas, 2～4 parts of Radix Dipsacis, 2～4 parts of Semen Cucumidis sativi.
3, the medicine of treatment sciatica according to claim 2, wherein the weight portion proportioning of each raw material of Chinese medicine is: 3 parts of Olibanums, 3 parts of Myrrhas, 3 parts on Flos Carthami, 3 parts of thirst due to hemorrhage, 3 parts in Radix Rubiae, 3 parts of Rhizoma Drynariae, 3 parts of Pyritums, 3 parts of Radix Notoginseng, 3 parts of Eupolyphaga Seu Steleophagas, 3 parts of Radix Dipsacis, 3 parts of Semen Cucumidis sativi.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100973299A CN101264197B (en) | 2008-05-13 | 2008-05-13 | Medicine for treating sciatica |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100973299A CN101264197B (en) | 2008-05-13 | 2008-05-13 | Medicine for treating sciatica |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101264197A true CN101264197A (en) | 2008-09-17 |
| CN101264197B CN101264197B (en) | 2010-09-29 |
Family
ID=39987038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100973299A Expired - Fee Related CN101264197B (en) | 2008-05-13 | 2008-05-13 | Medicine for treating sciatica |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101264197B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106138734A (en) * | 2016-08-13 | 2016-11-23 | 包莉丽 | A kind of medicine for treating sciatica |
| CN106361786A (en) * | 2016-11-07 | 2017-02-01 | 陈润火 | Oral and external medicines for treating sciatica and preparation methods thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1164308C (en) * | 2001-12-26 | 2004-09-01 | 邹明义 | Osteological Chinese medicine prepn. |
| CN1259924C (en) * | 2003-03-24 | 2006-06-21 | 王纯 | Chinese medicine for ftracture and preparation thereof |
| CN100381147C (en) * | 2006-06-09 | 2008-04-16 | 姜成武 | Rapid-acting bone wound capsules and preparation thereof |
-
2008
- 2008-05-13 CN CN2008100973299A patent/CN101264197B/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106138734A (en) * | 2016-08-13 | 2016-11-23 | 包莉丽 | A kind of medicine for treating sciatica |
| CN106361786A (en) * | 2016-11-07 | 2017-02-01 | 陈润火 | Oral and external medicines for treating sciatica and preparation methods thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101264197B (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101869691B (en) | Chinese medicinal composition for treating dysmenorrhea and preparation method thereof | |
| CN101961479A (en) | Chinese medicinal composition for treating bellyache and preparation method thereof | |
| CN101797352B (en) | Chinese medicinal composition for treating lassitude hypodynamia and preparation method thereof | |
| CN101810835A (en) | Chinese medicinal composition for treating purpura and preparation method thereof | |
| CN101972432B (en) | Chinese medicinal composition for treating diarrhea associated with menstruation and preparation method thereof | |
| CN101940694B (en) | Medicament for regulating sub-health of human body | |
| CN104069162B (en) | A kind of Chinese medicine for treating urarthritis and various bone joint pains | |
| CN101757500A (en) | Traditional Chinese medicine composition for treating typhitis and preparation method thereof | |
| CN101264197B (en) | Medicine for treating sciatica | |
| CN101810787A (en) | Chinese medicinal composition for treating dysphoria and preparation method thereof | |
| CN101829315B (en) | Traditional Chinese medicine composition for treating headache during menstruation and preparation method thereof | |
| CN102125678B (en) | Chinese medicinal preparation for treating hysteria disease | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN103610982A (en) | Medicine for treating rheumatic arthritis | |
| CN104306649B (en) | A kind of medicament for the treatment of herpes zoster | |
| CN101700373B (en) | Traditional Chinese medicine used for smoking cessation | |
| CN103919895B (en) | The Chinese medicinal liquor of a kind of the intestines and stomach coordinating, treatment constipation | |
| CN102698065B (en) | Medicine composition for treating primary dysmenorrhea | |
| CN101757396B (en) | Traditional Chinese medicine composition for treating deficiency of kidney qi and impotence and spermatorrhea and preparation method thereof | |
| CN1055238C (en) | Calming and desadening pill preparing process thereof | |
| CN103223052A (en) | Traditional Chinese medicine used for treating prostatitis | |
| CN102335360B (en) | Chinese medicine for treating metal disorder | |
| CN103070992B (en) | Medicine for treating high myopia macular hemorrhages | |
| CN101716321A (en) | Traditional Chinese medicine composition for treating heart vessel blockage stasis disease and preparation method thereof | |
| CN102552503B (en) | Traditional Chinese medicine powder used for treating cervical erosion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 265400 Shandong province Zhaoyuan City Shing Road Building Zhaojin Technology Center 108 Building No. 9 Patentee after: Xu Yonglin Address before: 1 groups of Spring Township elm village 133300 Jilin city of Hunchun Province Patentee before: Xu Yonglin |
|
| DD01 | Delivery of document by public notice |
Addressee: Xu Yonglin Document name: Notification to Pay the Fees |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100929 Termination date: 20140513 |